2020 was certainly an unusual year—for SME, for our industry, and for the world. There is no question that these unusual times will carry over into 2021. Unusual does not necessarily mean bad; it just means different. Often hidden within those differences are opportunities.
Imagine hearing the news that manufacturers are producing a proven and safe vaccine for COVID-19 and shipping it your way. It will be music to the world’s ears.
As 3D printing becomes integral to modern manufacturing operations, it must become integrated into supporting enterprise systems and interwoven with the latest industrial manufacturing methods
During times like these, editors turn to “tried and true” sayings to frame their opinion columns. One of these sayings is, “May you live in interesting times,” supposedly a translation of a traditional Chinese curse. The saying is used ironically, in that “interesting times” are times of trouble and difficulty.
Automated manufacturing operations are finely tuned ecosystems in which all components must function in complete harmony. Grippers used to pick and place, orient and hold components or end products at various points along the production chain are key to this process.
The low temperature intrinsic to solid-state printing processes allows manufacturers to weld layers of dissimilar metals without fear of metallurgical incompatibility issues.
It’s easy to become dazed by the continuing stream of buzz words. For those of us in manufacturing, all this buzz creates a sense of impending change, but no clarity on what that change might be. Uncertainty means anxiety.
Nearly a year ago, the world became aware of a new computer virus known as WannaCry. Many institutions were affected by the ransomware. It encrypted and locked a Microsoft Windows computing system and demanded payment.
The next cycle of technology disruption is upon us. Artificial Intelligence (AI) is taking hold in every industry and manufacturing is no exception. AI enables companies—from medical device and electronics manufacturers to pharmaceutical firms—to leverage their Big Data and IoT investments to see new patterns and insights and to perform tasks more efficiently and quickly than ever before.
Companies like ABB, Balluff and Sick would be within their rights to film a commercial with exuberant sensor product managers breaking out in a song of cheer.
